Solasia Pharma K.K.

4597・Growth Market・Pharmaceuticals

Official website

Solasia Pharma K.K.

4597・Growth Market・Pharmaceuticals

Official website

Solasia Pharma K.K.4597

Reference Indicators

Market Cap

74¥100M

P/E (Forecast)

—

P/B

4.1x

Dividend Yield (Forecast)

0.00%

ROE

-50.0%

EV/EBITDA

—

Financial Summary

Unit: ¥M

Item	2021Dec 2021	2022Dec 2022	2023Dec 2023	2024Dec 2024	2025Dec 2025
Net Sales	559	1,092	617	316	429
Cost of Sales	185	430	280	131	221
Gross Profit	373	662	337	185	207
SG&A Expenses	1,948	2,250	1,073	1,721	637
Operating Income	-2,419	-2,470	-1,139	-1,951	-861
Pre-tax Income	-2,442	-2,492	-1,135	-1,961	-876
Income Taxes	35	56	-22	-19	0
Net Income	-2,478	-2,548	-1,112	-1,941	-876
EBITDA	-1,924	-1,936	-639	-1,756	-824
Gross Margin	66.7%	60.6%	54.6%	58.5%	48.3%
Operating Margin	-432.7%	-226.2%	-184.6%	-617.4%	-200.7%
ROA	-78.8%	-81.3%	-49.9%	-142.5%	-40.8%
ROE	-95.8%	-95.7%	-59.3%	-167.9%	-50.0%